These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32087236)

  • 21. Role of Non-Statins, LDL-C Thresholds, and Special Population Considerations: A Look at the Updated 2016 ACC Consensus Committee Recommendations.
    Adhyaru BB; Jacobson TA
    Curr Atheroscler Rep; 2017 Jun; 19(6):29. PubMed ID: 28500517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current perceptions and practices in lipid management: results of a European Society of Cardiology/European Atherosclerosis Society Survey.
    Koskinas KC; Catapano AL; Baigent C; Tokgozoglu L; Mach F
    Eur J Prev Cardiol; 2022 Feb; 28(18):2030-2037. PubMed ID: 33580792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Statin associated myopathy in clinical practice. Results of DAMA study].
    Millán J; Pedro-Botet J; Climent E; Millán J; Rius J
    Clin Investig Arterioscler; 2017; 29(1):7-12. PubMed ID: 27717598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study.
    Hamoui O; Omar MI; Raal FJ; Rashed W; Kane A; Alami M; Abreu P; Mashhoud W; Alsheikh-Ali AA
    BMC Cardiovasc Disord; 2019 Mar; 19(1):61. PubMed ID: 30876390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing statin-induced muscle toxicity in a lipid clinic.
    Blaier O; Lishner M; Elis A
    J Clin Pharm Ther; 2011 Jun; 36(3):336-41. PubMed ID: 21414023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of low-density lipoprotein cholesterol levels in South Africa: the International ChoLesterol management Practice Study (ICLPS).
    Blom DJ; Raal F; Amod A; Naidoo P; Lai YE;
    Cardiovasc J Afr; 2019 Jan/Feb 23; 30(1):15-23. PubMed ID: 30720848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing statin myopathy.
    Venero CV; Thompson PD
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):121-36. PubMed ID: 19217515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statin myopathy: the iceberg or its tip?
    Campbell WW
    Muscle Nerve; 2006 Oct; 34(4):387-90. PubMed ID: 16810688
    [No Abstract]   [Full Text] [Related]  

  • 29. Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.
    Cicero AFG; Colletti A; Bajraktari G; Descamps O; Djuric DM; Ezhov M; Fras Z; Katsiki N; Langlois M; Latkovskis G; Panagiotakos DB; Paragh G; Mikhailidis DP; Mitchenko O; Paulweber B; Pella D; Pitsavos C; Reiner Ž; Ray KK; Rizzo M; Sahebkar A; Serban MC; Sperling LS; Toth PP; Vinereanu D; Vrablík M; Wong ND; Banach M
    Nutr Rev; 2017 Sep; 75(9):731-767. PubMed ID: 28938795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin-induced myopathy: a review and update.
    Abd TT; Jacobson TA
    Expert Opin Drug Saf; 2011 May; 10(3):373-87. PubMed ID: 21342078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Creatine as a Candidate to Prevent Statin Myopathy.
    Balestrino M; Adriano E
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31533334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statin intolerance - a question of definition.
    Algharably EA; Filler I; Rosenfeld S; Grabowski K; Kreutz R
    Expert Opin Drug Saf; 2017 Jan; 16(1):55-63. PubMed ID: 27645111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin-related myotoxicity.
    Fernandes V; Santos MJ; Pérez A
    Endocrinol Nutr; 2016 May; 63(5):239-49. PubMed ID: 27005745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statin-induced myopathies.
    Tomaszewski M; Stępień KM; Tomaszewska J; Czuczwar SJ
    Pharmacol Rep; 2011; 63(4):859-66. PubMed ID: 22001973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expert opinion: the therapeutic challenges faced by statin intolerance.
    Patel J; Martin SS; Banach M
    Expert Opin Pharmacother; 2016 Aug; 17(11):1497-507. PubMed ID: 27254275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intense physical exercise, muscle involvement and statin use].
    Toussirot E; Michel F; Meneveau N
    Presse Med; 2014 Jun; 43(6 Pt 1):726-7. PubMed ID: 24630267
    [No Abstract]   [Full Text] [Related]  

  • 37. Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients.
    Gitt AK; Lautsch D; Ferrieres J; Kastelein J; Drexel H; Horack M; Brudi P; Vanneste B; Bramlage P; Chazelle F; Sazonov V; Ambegaonkar B
    Atherosclerosis; 2016 Dec; 255():200-209. PubMed ID: 27667299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical aspects in the management of statin-associated muscle symptoms (SAMS).
    Laufs U; Filipiak KJ; Gouni-Berthold I; Catapano AL;
    Atheroscler Suppl; 2017 Apr; 26():45-55. PubMed ID: 28434484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S
    Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Nutraceuticals in Statin Intolerant Patients.
    Banach M; Patti AM; Giglio RV; Cicero AFG; Atanasov AG; Bajraktari G; Bruckert E; Descamps O; Djuric DM; Ezhov M; Fras Z; von Haehling S; Katsiki N; Langlois M; Latkovskis G; Mancini GBJ; Mikhailidis DP; Mitchenko O; Moriarty PM; Muntner P; Nikolic D; Panagiotakos DB; Paragh G; Paulweber B; Pella D; Pitsavos C; Reiner Ž; Rosano GMC; Rosenson RS; Rysz J; Sahebkar A; Serban MC; Vinereanu D; Vrablík M; Watts GF; Wong ND; Rizzo M;
    J Am Coll Cardiol; 2018 Jul; 72(1):96-118. PubMed ID: 29957236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.